Clinical characteristics and genotype-phenotype correlation in 62 patients with X-linked agammaglobulinemia
- PMID: 19904586
- DOI: 10.1007/s10875-009-9341-5
Clinical characteristics and genotype-phenotype correlation in 62 patients with X-linked agammaglobulinemia
Abstract
Introduction: X-linked agammagobulinemia (XLA) is a primary immunodeficiency disorder caused by Bruton's tyrosine kinase (Btk) gene mutation. Recent studies suggested genotype-phenotype correlation in XLA, but a definitive association remains controversial.
Patients and methods: We examined the relationship between specific Btk gene mutations and severity of clinical presentation in 62 patients with XLA. Disease severity was assessed by the age of disease onset and the presence of severe infections, while mutations were classified into severe and mild based on structural and functional consequence by bioinformatics analysis.
Results: Fifty-six Btk mutations were identified in 62 patients from 57 kindreds. Variation in phenotypes was observed, and there was a tendency of association between genotype and age of disease onset as well as occurrence of severe infections.
Conclusion: A critical analysis of the circumstances upon presentation also revealed that under-recognition of recurrent infections and relevant family history are important hurdles to timely diagnosis of XLA.
Similar articles
-
Mutation of the BTK gene and clinical feature of X-linked agammaglobulinemia in mainland China.J Clin Immunol. 2009 May;29(3):352-6. doi: 10.1007/s10875-008-9262-8. Epub 2008 Nov 28. J Clin Immunol. 2009. PMID: 19039656
-
Clinical characteristics and genetic profiles of 174 patients with X-linked agammaglobulinemia: Report from Shanghai, China (2000-2015).Medicine (Baltimore). 2016 Aug;95(32):e4544. doi: 10.1097/MD.0000000000004544. Medicine (Baltimore). 2016. PMID: 27512878 Free PMC article.
-
Mutation screening of the BTK gene in 56 families with X-linked agammaglobulinemia (XLA): 47 unique mutations without correlation to clinical course.Pediatrics. 1998 Feb;101(2):276-84. doi: 10.1542/peds.101.2.276. Pediatrics. 1998. PMID: 9445504
-
Bruton tyrosine kinase (BTK) in X-linked agammaglobulinemia (XLA).Front Biosci. 2000 Dec 1;5:D917-28. doi: 10.2741/vihinen. Front Biosci. 2000. PMID: 11102316 Review.
-
The clinical spectrum of Bruton's agammaglobulinemia.Curr Allergy Asthma Rep. 2001 Nov;1(6):558-65. doi: 10.1007/s11882-001-0065-8. Curr Allergy Asthma Rep. 2001. PMID: 11892085 Review.
Cited by
-
Clinical characteristics and prenatal diagnosis for 22 families in Henan Province of China with X-linked agammaglobulinemia (XLA) related to Bruton's tyrosine kinase (BTK) gene mutations.BMC Med Genet. 2020 Jun 17;21(1):131. doi: 10.1186/s12881-020-01063-5. BMC Med Genet. 2020. PMID: 32552675 Free PMC article.
-
Fatal Progressive Meningoencephalitis Diagnosed in Two Members of a Family With X-Linked Agammaglobulinemia.Front Pediatr. 2020 Sep 18;8:579. doi: 10.3389/fped.2020.00579. eCollection 2020. Front Pediatr. 2020. PMID: 33042921 Free PMC article.
-
Intracranial abscess as a complication of X-linked agammaglobulinemia.Childs Nerv Syst. 2016 Nov;32(11):2049-2051. doi: 10.1007/s00381-016-3219-7. Epub 2016 Aug 22. Childs Nerv Syst. 2016. PMID: 27550432 No abstract available.
-
Chronic Lung Disease in Primary Antibody Deficiency: Diagnosis and Management.Immunol Allergy Clin North Am. 2020 Aug;40(3):437-459. doi: 10.1016/j.iac.2020.03.003. Epub 2020 Jun 9. Immunol Allergy Clin North Am. 2020. PMID: 32654691 Free PMC article. Review.
-
Uncovering Low-Level Maternal Gonosomal Mosaicism in X-Linked Agammaglobulinemia: Implications for Genetic Counseling.Front Immunol. 2020 Feb 12;11:46. doi: 10.3389/fimmu.2020.00046. eCollection 2020. Front Immunol. 2020. PMID: 32117230 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources